Skip to content
2000
Volume 19, Issue 1
  • ISSN: 1573-4072
  • E-ISSN: 1875-6646

Abstract

Background: Ramalin (γ-glutamyl-N'-(2-hydroxyphenyl) hydrazide), a nitrogencontaining lichen secondary metabolite, was isolated from Ramalina terebrata, an Antarctic lichen. Since then, it has attracted several researchers, thus leading to various research investigations exploring the pharmacological potential of Ramalin. Methods: The bibliographic databases were explored for the peer-reviewed research related to the pharmacological importance of Ramalin. Results: The article summarizes the antioxidant, anti-cancer, anti-obesity, antibacterial, and antiallergic activities of this molecule. Additionally, the studies conducted to show the potential of Ramalin in atherosclerosis, atopic dermatitis, neurodegenerative disorders, hepatic fibrosis and its role in autophagy suppression and enzyme inhibition are also described briefly. Moreover, the experimental findings also depict that Ramalin did not show any toxicity. Conclusion: The current review shall be beneficial for future researchers interested in working on Ramalin because it summarizes all the relevant publications starting from its first-time isolation to the articles of 2021.

Loading

Article metrics loading...

/content/journals/cbc/10.2174/1573407218666220324120229
2023-01-01
2025-07-25
Loading full text...

Full text loading...

/content/journals/cbc/10.2174/1573407218666220324120229
Loading

  • Article Type:
    Review Article
Keyword(s): anti-cancer; anti-inflammatory; antioxidant; Lichen; ramalin; Ramalina terebrata
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test